Physician profile
Christopher E Selgrath
NPI 1801990361
$1,145.36
in general payments reported to CMS, 2019-2025
16 companies · $32.33 in 2025
The $32.33 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.19 · 2020: $53.13 · 2021: $268 · 2022: $205 · 2023: $272 · 2024: $285 · 2025: $32.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356 · Education: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.56 |
| Education | $233.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $431.85 | 2019-2023 | Na |
| Zimmer Biomet Holdings, INC. | $335.52 | 2023-2024 | Oxford, Gel-One Cross-Linked Hyaluronate |
| Heraeus Medical, LLC. | $83.06 | 2021-2024 | Palacos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.91 | 2022-2023 | Lifevest |
| Vertex Pharmaceuticals Incorporated | $32.33 | 2025 | |
| Wright Medical Technology, INC. | $30.53 | 2020 | |
| Ethicon US, LLC | $22.60 | 2020 | |
| Edwards Lifesciences Corporation | $20.18 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amgen INC. | $16.52 | 2023 | Repatha |
| Pfizer INC. | $16.43 | 2023 | |
| Smith+Nephew, INC. | $16.32 | 2023 | Stravix, Grafix Pl, Stravix Pl |
| Integra Lifesciences Corporation | $15.23 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Merck Sharp & Dohme LLC | $14.82 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.41 | 2019 | |
| Endo Pharmaceuticals INC. | $14.31 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $8.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Selgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.